About Vyome Holdings Inc
- Industry: Pharmaceuticals
- Exchange: NASDAQ NMS - GLOBAL MARKET
- Country: US
- Website: https://www.reshapelifesciences.com/obalon/
Frequently Asked Questions
What is the 52-week range for HIND?
The 52-week high is $6.56 and the 52-week low is $1.75.
What is the P/E ratio for HIND?
The P/E ratio data is currently unavailable.
What is the dividend yield for HIND?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is -254.62%.
What is the Net Profit Margin?
The Net Profit Margin (TTM) is -8716.36%.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 7.95.
Analyst Recommendation Trends
Wall Street analyst consensus for HIND over the last few months:
Latest HIND News
Vyome Holdings' ReShape Lifesciences Has Received A Notice Of Allowance For A U.S. Patent Titled "VAGUS NERVE NEUROMODULATION FOR THE TREATMENT OF THE HYPOGLYCEMIC STATE".
https://patentcenter.uspto.gov/applications/18702356/ifw/docs
Vyome Appoints Experienced Public Company Finance Executive Jerry Leonard as Chief Financial Officer
CAMBRIDGE, Mass., September 14, 2026--Vyome Holdings, Inc. (Nasdaq: HIND) ("Vyome" or the "Company"), a clinical-stage biopharmaceutical company focused on developing differentiated therapies for immuno-inflammatory and rare disease conditions, today announced the appointment of senior financial executive Jerry Leonard, CPA, MBA, as Chief Financial Officer. Mr. Leonard has assumed the role from September 1st, 2026 and will oversee the Company’s financial operations, financial reporting, accounti
Vyome Holdings Appoints Jerry Leonard As CFO, Succeeding Robert Dickey IV, Who Served As Interim CFO Since August 2025
Finance executive with more than 25 years of experience brings extensive expertise in public company financial management, SEC reporting, financial operations, and governanceVyome Holdings, Inc. (NASDAQ:HIND)
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-09-01 | Jolly Mohanjit | +120,000 | - | - |
| 2025-11-13 | Pomichter Stanley D III | +17,833 | - | - |
| 2025-11-13 | Tincoff John M. III | +17,833 | - | - |
| 2025-11-13 | Sengupta Shiladitya | +624,432 | - | - |
| 2025-11-13 | Nelabhotla Venkateswarlu | +615,149 | - | - |